Literature DB >> 30014478

4D robust optimization including uncertainties in time structures can reduce the interplay effect in proton pencil beam scanning radiation therapy.

Erik Engwall1, Albin Fredriksson1, Lars Glimelius1.   

Abstract

PURPOSE: Interplay effects in proton radiotherapy can create large distortions in the dose distribution and severely degrade the plan quality. Standard methods to mitigate these effects include abdominal compression, gating, and rescanning. We propose a new method to include the time structures of the delivery and organ motion in the framework of four-dimensional (4D) robust optimization to generate plans that are robust against interplay effects.
METHODS: The method considers multiple scenarios reflecting the uncertainties in the delivery and in the organ motion. In each scenario, the pencil beam scanning spots are distributed to different phases of the breathing cycle according to each individual spot time stamp, and a partial beam dose is calculated for each phase. The partial beam doses are accumulated on a reference phase through deformable image registrations. Minimax optimization is performed to take all scenarios into account simultaneously. For simplicity, the uncertainties in this proof of concept study are limited to variations in the breathing pattern. The method is evaluated for three different nonsmall cell lung cancer patients and compared to plans using conventional 4D robust optimization both with and without rescanning. We assess the ability of the method to mitigate distortions from the interplay effect over multiple evaluation scenarios using 4D dose calculations. This interplay evaluation is performed in an experimentally validated framework, which is independent of the optimization in the plan generation step.
RESULTS: For the three studied patients, 4D optimization including time structures is efficient, especially for large tumor motions, where rescanning of conventional 4D robustly optimized plans is not sufficient to mitigate the interplay effect. The most efficient approach of the new method is achieved when it is combined with rescanning. For the patient with the largest motion, the mean V95% is 99.2% and mean V107% is 3.65% for the best rescanned 4D plan optimized with time structure. This can be compared to conventional 4D optimized plans with mean V95% of 92.7% and mean V107% of 13.1%.
CONCLUSIONS: The current study shows the potential of reducing interplay effects in proton pencil beam scanning radiotherapy by incorporating organ motion and delivery characteristics in a 4D robust optimization.
© 2018 American Association of Physicists in Medicine.

Entities:  

Keywords:  4D optimization; interplay effect; motion mitigation; proton therapy; rescanning; robust optimization

Year:  2018        PMID: 30014478     DOI: 10.1002/mp.13094

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  20 in total

Review 1.  Proton beam therapy for tumors of the upper abdomen.

Authors:  Ann Raldow; James Lamb; Theodore Hong
Journal:  Br J Radiol       Date:  2019-08-23       Impact factor: 3.039

Review 2.  Adaptive proton therapy.

Authors:  Harald Paganetti; Pablo Botas; Gregory C Sharp; Brian Winey
Journal:  Phys Med Biol       Date:  2021-11-15       Impact factor: 3.609

3.  Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.

Authors:  Jie Shan; Yunze Yang; Steven E Schild; Thomas B Daniels; William W Wong; Mirek Fatyga; Martin Bues; Terence T Sio; Wei Liu
Journal:  Med Phys       Date:  2020-10-13       Impact factor: 4.071

Review 4.  Proton therapy for non-small cell lung cancer: the road ahead.

Authors:  Eric D Brooks; Matthew S Ning; Vivek Verma; X Ronald Zhu; Joe Y Chang
Journal:  Transl Lung Cancer Res       Date:  2019-09

5.  Impact of errors in spot size and spot position in robustly optimized pencil beam scanning proton-based stereotactic body radiation therapy (SBRT) lung plans.

Authors:  Suresh Rana; Anatoly B Rosenfeld
Journal:  J Appl Clin Med Phys       Date:  2021-06-07       Impact factor: 2.102

6.  Technical Note: Multiple energy extraction techniques for synchrotron-based proton delivery systems may exacerbate motion interplay effects in lung cancer treatments.

Authors:  James E Younkin; Danairis Hernandez Morales; Jiajian Shen; Xiaoning Ding; Joshua B Stoker; Nathan Y Yu; Terence T Sio; Thomas B Daniels; Martin Bues; Mirek Fatyga; Steven E Schild; Wei Liu
Journal:  Med Phys       Date:  2021-07-29       Impact factor: 4.506

7.  Assessment of a diaphragm override strategy for robustly optimized proton therapy planning for esophageal cancer patients.

Authors:  Sabine Visser; Hendrike Neh; Cássia Oraboni Ribeiro; Erik W Korevaar; Arturs Meijers; Björn Poppe; Nanna M Sijtsema; Stefan Both; Johannes A Langendijk; Christina T Muijs; Antje C Knopf
Journal:  Med Phys       Date:  2021-08-05       Impact factor: 4.506

Review 8.  Roadmap: proton therapy physics and biology.

Authors:  Harald Paganetti; Chris Beltran; Stefan Both; Lei Dong; Jacob Flanz; Keith Furutani; Clemens Grassberger; David R Grosshans; Antje-Christin Knopf; Johannes A Langendijk; Hakan Nystrom; Katia Parodi; Bas W Raaymakers; Christian Richter; Gabriel O Sawakuchi; Marco Schippers; Simona F Shaitelman; B K Kevin Teo; Jan Unkelbach; Patrick Wohlfahrt; Tony Lomax
Journal:  Phys Med Biol       Date:  2021-02-26       Impact factor: 4.174

9.  Measurement-based study on characterizing symmetric and asymmetric respiratory motion interplay effect on target dose distribution in the proton pencil beam scanning.

Authors:  Eunsin Lee; Daniel Perry; Joseph Speth; Yongbin Zhang; Zhiyan Xiao; Anthony Mascia
Journal:  J Appl Clin Med Phys       Date:  2020-03-14       Impact factor: 2.102

10.  Feasibility study: spot-scanning proton arc therapy (SPArc) for left-sided whole breast radiotherapy.

Authors:  Sheng Chang; Gang Liu; Lewei Zhao; Joshua T Dilworth; Weili Zheng; Saada Jawad; Di Yan; Peter Chen; Craig Stevens; Peyman Kabolizadeh; Xiaoqiang Li; Xuanfeng Ding
Journal:  Radiat Oncol       Date:  2020-10-07       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.